Duloxetine, a Selective Noradrenaline Reuptake Inhibitor, Increased Plasma Levels of 3-Methoxy-4-hydroxyphenylglycol but Not Homovanillic Acid in Patients with Major Depressive Disorder

Benzer Materyaller

• Catechol-O-methyltransferase Val158Met genotype and the clinical responses to duloxetine treatment or plasma levels of 3-methoxy-4-hydroxyphenylglycol and homovanillic acid in Japanese patients with major depressive disorder
  Yazar:: Atake, Kiyokazu, ve diğerleri
  Baskı/Yayın Bilgisi: (2015)
• Serum levels of brain-derived neurotrophic factor (BDNF), proBDNF and plasma 3-methoxy-4-hydroxyphenylglycol levels in chronic schizophrenia
  Yazar:: Yoshimura, Reiji, ve diğerleri
  Baskı/Yayın Bilgisi: (2016)
• Comparison of lithium, aripiprazole and olanzapine as augmentation to paroxetine for inpatients with major depressive disorder
  Yazar:: Yoshimura, Reiji, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• Serum Levels of Brain-Derived Neurotrophic Factor at 4 Weeks and Response to Treatment with SSRIs
  Yazar:: Yoshimura, Reiji, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• Serum proBDNF/BDNF and response to fluvoxamine in drug-naïve first-episode major depressive disorder patients
  Yazar:: Yoshimura, Reiji, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)